{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T11:58:43Z","timestamp":1785585523026,"version":"3.56.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","funder":[{"name":"Louise Von Hess Medical Research Institute Foundation"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"\n OBJECTIVES:<\/jats:title>\n To evaluate whether preoperative intravenous tranexamic acid (TXA) reduces postoperative blood transfusion rates in geriatric patients undergoing operative treatment for hip fracture.<\/jats:p>\n <\/jats:sec>\n \n METHODS:<\/jats:title>\n <\/jats:sec>\n \n Design:<\/jats:title>\n Prospective, double-blinded, randomized controlled trial terminated early after interim futility analysis.<\/jats:p>\n <\/jats:sec>\n \n Setting:<\/jats:title>\n Single-center Level I trauma center.<\/jats:p>\n <\/jats:sec>\n \n Patient Selection Criteria:<\/jats:title>\n Patients aged \u226565 years who underwent operative treatment for femoral neck (AO\/OTA 31-B), intertrochanteric region (AO\/OTA 31-A), or subtrochanteric (AO\/OTA 32-A\/B\/C) fractures between June 2019 and June 2022 were included. Procedures included arthroplasty (hemiarthroplasty or total hip arthroplasty) and internal fixation (ORIF) with intramedullary nailing or sliding hip screw fixation. Exclusion criteria were recent thromboembolic events, cancer, hypercoagulable disorders, or TXA allergy.<\/jats:p>\n <\/jats:sec>\n \n Outcome Measures and Comparisons:<\/jats:title>\n The primary outcome was postoperative transfusion. Secondary outcomes included hospital length of stay, 30-day readmission, and 90-day complications and mortality. Statistical comparisons were performed using odds ratios, chi-squared, and t-tests, with significance thresholds adjusted by O'Brien\u2013Fleming criteria.<\/jats:p>\n <\/jats:sec>\n \n RESULTS:<\/jats:title>\n \n A total of 283 patients were analyzed {TXA: 146 [mean age 84 (range 65\u2013100), 71.9% female; placebo: 137 [mean age 83.1 (range 65\u2013100), 77.2% female]}. Baseline characteristics, including body mass index and procedure type, were comparable (all\n P<\/jats:italic>\n > 0.05). A total of 229 patients (80.9%) required no postoperative transfusion (TXA 81%; placebo: 81%,\n P<\/jats:italic>\n = 0.97). No significant differences were observed in 30-day readmission (\n P<\/jats:italic>\n = 0.729), 90-day complications (\n P<\/jats:italic>\n = 0.183), hospital length of stay (\n P<\/jats:italic>\n = 0.783), or 90-day mortality (\n P<\/jats:italic>\n = 0.655). Subgroup analysis revealed higher transfusion rates in ORIF versus arthroplasty (ORIF 25%, arthroplasty 8%,\n P<\/jats:italic>\n < 0.05), although no difference between TXA and placebo within subgroups (\n P<\/jats:italic>\n = 0.38).\n <\/jats:p>\n <\/jats:sec>\n \n CONCLUSIONS:<\/jats:title>\n Preoperative TXA was not associated with reduced transfusion requirements in geriatric hip fracture surgery. No significant differences were observed in complications, mortality, or hospital stay. Surgical procedure may influence transfusion risk more than TXA use.<\/jats:p>\n <\/jats:sec>\n \n Level of Evidence:<\/jats:title>\n Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.<\/jats:p>\n <\/jats:sec>","DOI":"10.1097\/bot.0000000000003172","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T13:00:20Z","timestamp":1773666020000},"page":"341-347","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["The Effect of Preoperative Tranexamic Acid on Blood Transfusions in Geriatric Hip Fracture Surgery: A Randomized Controlled Trial"],"prefix":"10.1097","volume":"40","author":[{"given":"Megan","family":"Sullivan","sequence":"first","affiliation":[{"name":"Department of Orthopedic Surgery, Philadelphia College of Osteopathic Medicine, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1930-1175","authenticated-orcid":false,"given":"Lindsey L.","family":"Perea","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Trauma and Acute Care Surgery, Penn Medicine Lancaster General Health, Lancaster, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Bradburn","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Trauma and Acute Care Surgery, Penn Medicine Lancaster General Health, Lancaster, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Guglielmo","sequence":"additional","affiliation":[{"name":"Data and Analytics (DnA), Penn Medicine, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kellie","family":"Bresz","sequence":"additional","affiliation":[{"name":"Data and Analytics (DnA), Penn Medicine, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Horst","sequence":"additional","affiliation":[{"name":"Data and Analytics (DnA), Penn Medicine, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Martin","sequence":"additional","affiliation":[{"name":"Research Institute, Penn Medicine Lancaster General Health, Lancaster, PA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Heinle","sequence":"additional","affiliation":[{"name":"Orthopedic Associates of Lancaster, Lancaster, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Tocks","sequence":"additional","affiliation":[{"name":"Orthopedic Associates of Lancaster, Lancaster, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260612","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.1016\/S2666-7568(23)00102-2","article-title":"Hip fractures: mortality, economic burden, and organizational factors for improved patient outcomes","volume":"4","author":"Liu","year":"2023","journal-title":"Lancet Healthy Longev"},{"key":"R2-20260612","first-page":"e74586","article-title":"Outcome and cost evaluation of hip fractures in elderly patients at a tertiary care hospital in the Caribbean","volume":"16","author":"Sanderson-Jerome","year":"2024","journal-title":"Cureus"},{"key":"R3-20260612","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.injury.2010.02.015","article-title":"The hidden blood loss after hip fracture","volume":"42","author":"Smith","year":"2011","journal-title":"Injury"},{"key":"R4-20260612","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1302\/0301-620X.88B8.17534","article-title":"Hidden blood loss after surgery for hip fracture","volume":"88","author":"Foss","year":"2006","journal-title":"J Bone Joint Surg Br"},{"key":"R5-20260612","first-page":"645","article-title":"Analysis of the hemoglobin level drop in patients with hip fracture after admission","volume":"56","author":"Kamiloski","year":"2017","journal-title":"Acta Clin Croat"},{"key":"R6-20260612","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.2106\/JBJS.N.00128","article-title":"Perioperative blood transfusions in orthopaedic surgery","volume":"96","author":"Ponnusamy","year":"2014","journal-title":"J Bone Joint Surg Am"},{"key":"R7-20260612","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(88)91536-X","article-title":"Severity of anaemic and operative mortality and morbidity","volume":"1","author":"Carson","year":"1988","journal-title":"Lancet"},{"key":"R8-20260612","doi-asserted-by":"crossref","first-page":"132","DOI":"10.5435\/00124635-201003000-00002","article-title":"Antifibrinolytics in major orthopaedic surgery","volume":"18","author":"Eubanks","year":"2010","journal-title":"J Am Acad Orthop Surg"},{"key":"R9-20260612","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.thromres.2008.09.015","article-title":"Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials","volume":"123","author":"Kagoma","year":"2009","journal-title":"Thrombosis Res"},{"key":"R11-20260612","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1016\/j.arth.2018.06.023","article-title":"The efficacy of tranexamic acid in total hip arthroplasty: a network meta-analysis","volume":"33","author":"Fillingham","year":"2018","journal-title":"J Arthroplasty"},{"key":"R12-20260612","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1016\/j.arth.2018.03.031","article-title":"The safety of tranexamic acid in total joint arthroplasty: a direct meta-analysis","volume":"33","author":"Fillingham","year":"2018","journal-title":"J Arthroplasty"},{"key":"R13-20260612","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13018-015-0188-6","article-title":"Transfusions and blood loss in total hip and knee arthroplasty: a prospective observational study","volume":"10","author":"Carling","year":"2015","journal-title":"J Orthop Surg Res"},{"key":"R14-20260612","first-page":"1969e74","article-title":"Topical (intra- articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement: a randomized controlled trial (TRANX-H) (provisional abstract)","volume":"95","author":"Alshryda","year":"2013","journal-title":"J Bone Joint Surg Am"},{"key":"R15-20260612","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/000164700317411834","article-title":"Tranexamic acid given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty","volume":"71","author":"Benoni","year":"2000","journal-title":"Acta Orthop Scand"},{"key":"R16-20260612","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1302\/0301-620X.91B6.22393","article-title":"The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement","volume":"91","author":"Rajesparan","year":"2009","journal-title":"J Bone Joint Surg Br"},{"key":"R17-20260612","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.arth.2015.12.001","article-title":"Topical vs intra- venous tranexamic acid in primary total hip arthroplasty: a double-blind, randomized controlled trial","volume":"31","author":"North","year":"2016","journal-title":"J Arthroplasty"},{"key":"R18-20260612","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2106\/JBJS.16.00188","article-title":"Oral and intravenous tranexamic acid are equivalent at reducing blood loss following total hip arthroplasty: a randomized controlled trial","volume":"99","author":"Kayupov","year":"2017","journal-title":"J Bone Joint Surg Am"},{"key":"R19-20260612","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.arth.2012.04.024","article-title":"Tranexamic acid for reduction of blood loss during total hip arthroplasty","volume":"27","author":"Imai","year":"2012","journal-title":"J Arthroplasty"},{"key":"R20-20260612","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.arth.2016.02.081","article-title":"The James A. A randomized controlled trial of oral and intravenous tranexa- mic acid in total knee arthroplasty: the same efficacy at lower cost?","volume":"31","author":"Fillingham","year":"2016","journal-title":"J Arthroplasty"},{"key":"R21-20260612","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.2106\/JBJS.N.00060","article-title":"Topical intra-articular compared with intravenous tra- nexamic acid to reduce blood loss in primary total knee replacement: a double-blind, randomized, controlled, noninferiority clinical trial","volume":"96","author":"Gomez-Barrena","year":"2014","journal-title":"J Bone Joint Surg Am"},{"key":"R22-20260612","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.arth.2014.01.038","article-title":"Weighted versus uniform dose of tranexamic acid in patients undergoing primary, elective knee arthroplasty: a prospective randomized controlled trial","volume":"29","author":"Levine","year":"2014","journal-title":"J Arthroplasty"},{"key":"R23-20260612","doi-asserted-by":"crossref","first-page":"2309499019887995","DOI":"10.1177\/2309499019887995","article-title":"Tranexamic acid in hip fracture surgery: a systematic review and meta-analysis","volume":"28","author":"Haj-Younes","year":"2020","journal-title":"J Orthop Surg (Hong Kong)"},{"key":"R24-20260612","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1097\/BOT.0000000000002440","article-title":"The use of tranexamic acid in hip fracture Surgery-A systematic review and meta-analysis","volume":"36","author":"Agius","year":"2022","journal-title":"J Orthop Trauma"},{"key":"R25-20260612","doi-asserted-by":"crossref","first-page":"103337","DOI":"10.1016\/j.otsr.2022.103337","article-title":"Intravenous tranexamic acid and thromboembolic events in hip fracture surgery: a systematic review and meta-analysis","volume":"109","author":"Leverett","year":"2023","journal-title":"Orthop Traumatol Surg Res"},{"key":"R26-20260612","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1016\/j.injury.2020.07.061","article-title":"Tranexamic acid in hip hemiarthroplasty","volume":"51","author":"Ashkenazi","year":"2020","journal-title":"Injury"},{"key":"R27-20260612","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s43465-022-00779-1","article-title":"Safety and efficacy of tranexamic acid in hip hemiarthroplasty for fracture neck femur: a systematic review and meta-analysis","volume":"57","author":"Tripathy","year":"2023","journal-title":"Indian J Orthop"},{"key":"R28-20260612","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.arth.2021.12.034","article-title":"Pre-emptive antifibrinolysis: its role and efficacy in hip fracture patients undergoing total hip arthroplasty","volume":"37","author":"Liu","year":"2022","journal-title":"J Arthroplasty"},{"key":"R29-20260612","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.otsr.2019.10.015","article-title":"Postoperative outcomes of tranexamic acid use in geriatric trauma patients treated with proximal femoral intramedullary nails: a systematic review and meta-analysis","volume":"106","author":"Xing","year":"2020","journal-title":"Orthop Traumatol Surg Res"},{"key":"R30-20260612","doi-asserted-by":"crossref","first-page":"104237","DOI":"10.1016\/j.otsr.2025.104237","article-title":"Evaluation of intravenous tranexamic acid in total hip arthroplasty for femoral neck fracture: a propensity score-matched, real-world analysis","volume":"112","author":"Pinon","year":"2026","journal-title":"Orthop Traumatol Surg Res"},{"key":"R31-20260612","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1503\/cjs.030413","article-title":"Factors affecting transfusion requirement after hip fracture: can we reduce the need for blood?","volume":"57","author":"Desai","year":"2014","journal-title":"Can J Surg"}],"container-title":["Journal of Orthopaedic Trauma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOT.0000000000003172","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T13:00:25Z","timestamp":1781269225000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOT.0000000000003172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/bot.0000000000003172","relation":{},"ISSN":["0890-5339","1531-2291"],"issn-type":[{"value":"0890-5339","type":"print"},{"value":"1531-2291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"2026-01-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}